Parañaque secures 200K AstraZeneca shots for residents | Inquirer News

Parañaque secures 200K AstraZeneca shots for residents

By: - Reporter / @ConsINQ
/ 10:37 AM January 13, 2021

MANILA, Philippines — The city government of Parañaque on Wednesday said it has signed a deal with UK pharmaceutical firm AstraZeneca for the purchase of 200,000 vaccine doses to be given to its residents for free.

“The purchase price is for $5 per dose, or a total of $1 million for the city government,” Parañaque Mayor Edwin Olivarez said in a statement, noting that he sealed the deal with the British drugmaker last Sunday, January 10.

In the same statement, city health officer Olga Virtusio said Phase 1 of their local vaccine program includes inoculation 119,200 residents, composed of frontline workers, uniformed personnel, indigents, senior citizens and persons with disabilities.

ADVERTISEMENT

The city, which has more than 600,000 residents, already prepared P1.25 billion for its vaccination program.

As of Jan. 12, the city reported a total of 8,342 cases of the severe respiratory disease, including 152 active cases, 7,975 recoveries and 215 deaths.

PARAÑAQUE CITY COVID-19 UPDATE!As of today, January 12, 2021, the total number of Active Cases in the City of…

Posted by Parañaque City – Public Information Office on Tuesday, January 12, 2021

EDV
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: AstraZeneca, COVID-19, Metro, Parañaque

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.